Megaloblastic anemia in the course of vinblastine sulphate (VELBE) therapy.
D000293:Adolescent; D000741:Anemia, Aplastic / Q000188:drug therapy; D000748:Anemia, Macrocytic / Q000209:etiology*; D001856:Bone Marrow Examination; D004906:Erythrocyte Count; D006689:Hodgkin Disease / Q000188:drug therapy*; D006801:Humans; D037102:Lectins / Q000627:therapeutic use; D007970:Leukopenia / Q000188:drug therapy / Q000209:etiology; D008297:Male; D009588:Nitrogen Mustard Compounds / Q000009:adverse effects; D014747:Vinblastine / Q000009:adverse effects*
D037102:Lectins; D009588:Nitrogen Mustard Compounds; D014747:Vinblastine